The dependence of the hemodynamic activity of human response to short-term general cooling of the initial content of neutrophils in the peripheral venous blood

2020 ◽  
pp. 21-25
Author(s):  
S.N. Balashova ◽  
A.V. Samodova ◽  
L.X. Dobrodeeva
Keyword(s):  
Venous Blood ◽  
Human Response ◽  
Short Term ◽  
Peripheral Venous Blood ◽  
General Cooling ◽  
Initial Content

Platelet Hyperaggregability in Ischemic Cerebrovascular Disease and Effects of Aspirin

1982 ◽  
Vol 48 (02) ◽  
pp. 117-119 ◽  
Author(s):  
M Kusunoki ◽  
K Kimura ◽  
K Nagatsuka ◽  
Y Isaka ◽  
O Uyama ◽  
...  
Keyword(s):  
Cerebrovascular Disease ◽  
Venous Blood ◽  
Second Phase ◽  
Cerebral Angiogram ◽  
Peripheral Venous Blood ◽  
Chronic Stage ◽  
Ischemic Cerebrovascular Disease ◽  
Carotid Arterial ◽  
Platelet Hyperaggregability ◽  
The Brain

SummaryPlatelet aggregation was studied in 24 patients in the chronic stage of ischemic cerebrovascular disease (CVD), with cerebral affluent and effluent blood, i.e., carotid arterial and internal jugular venous blood, and also with peripheral venous blood. Aggregation tests were performed at various final concentrations of sodium arachidonate (A.A.) and ADP. In 17 patients, not taking aspirin, platelet aggregability in jugular venous blood was significantly accentuated compared with that in arterial and peripheral venous blood. This tendency was more marked in the patients with cerebral artery stenosis and/or occlusion than in those with normal cerebral angiogram. In 7 patients taking 500 mg or more oral aspirin, aggregation differences across the brain were not observed and A.A. aggregation and the second phase of ADP aggregation were completely suppressed. These results suggest that a prophylactic administration of aspirin may be beneficial for patients in chronic stage of CVD.

Increased erythrocyte adhesiveness/aggregation in the peripheral venous blood of patients with ischaemic heart disease and an eventful course

2001 ◽  
Vol 56 (2) ◽  
pp. 121-126 ◽  
Author(s):  
Schlomo BERLINER ◽  
Rivka ROTSTEIN ◽  
Renato FUSMAN ◽  
Itzhak SHAPIRA ◽  
Ori ROGOWSKI ◽  
...  
Keyword(s):  
Heart Disease ◽  
Ischaemic Heart Disease ◽  
Venous Blood ◽  
Peripheral Venous Blood

Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood

Cancer ◽  
1995 ◽  
Vol 75 (9) ◽  
pp. 2214-2219 ◽  
Author(s):  
Toshiki Komeda ◽  
Yoshihiro Fukuda ◽  
Takehiro Sando ◽  
Ryuichi Kita ◽  
Motonobu Furukawa ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Venous Blood ◽  
Carcinoma Cells ◽  
Sensitive Detection ◽  
Hepatocellular Carcinoma Cells ◽  
Peripheral Venous Blood

A comparison of blood gases and acid-base measurements in arterial, arterialized venous, and venous blood during short-term maximal exercise

1990 ◽  
Vol 61 (3-4) ◽  
pp. 294-301 ◽  
Author(s):  
Jon Linderman ◽  
Thomas D. Fahey ◽  
Gregory Lauten ◽  
Alan S. Brooker ◽  
Doug Bird ◽  
...  
Keyword(s):  
Maximal Exercise ◽  
Venous Blood ◽  
Blood Gases ◽  
Acid Base ◽  
Short Term

scholarly journals Activated T Cells and Soluble Molecules in the Portal Venous Blood of Patients with Cholestatic and Hepatitis C Virus-Positive Liver Cirrhosis. Possible Promotion of Fas/FasL-Mediated Apoptosis in the Bile-Duct Cells and Hepatocyte Injury

2003 ◽  
Vol 31 (3) ◽  
pp. 170-180 ◽  
Author(s):  
N Ariki ◽  
Y Morimoto ◽  
T Yagi ◽  
T Oyama ◽  
Y Cyouda ◽  
...  
Keyword(s):  
T Cells ◽  
Liver Cirrhosis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Bile Duct ◽  
Venous Blood ◽  
Activated T Cells ◽  
Peripheral Venous Blood ◽  
Nk T Cells ◽  
Portal Venous Blood

We investigated the immune responses of patients with cholestatic and hepatitis C virus-positive (HCV-positive) liver cirrhosis by analysing T-cell subsets and cytokine levels in the portal and peripheral veins, using flow cytometry and enzyme-linked immunosorbent assay. In cholestatic liver cirrhosis, the proportion of natural-killer (NK) T cells and interleukin (IL) 6 and IL-18 levels in the portal venous blood were significantly higher than those in the peripheral venous blood. In HCV-positive liver cirrhosis, the proportions of NK T cells and Fas+ T cells and IL-6 and soluble Fas levels in the portal venous blood were significantly higher than those in the peripheral venous blood. These results suggest that in these diseases, activated T cells and soluble molecules in portal venous blood may promote Fas/FasL-mediated apoptosis of the bile-duct cells and hepatocytes, and contribute to the deterioration in liver function as an inevitable result of positive feedback.

Direct Measurement of the Hepatointestinal Extraction of Zinc in Cirrhosis and Hepatitis

1981 ◽  
Vol 61 (4) ◽  
pp. 441-444 ◽  
Author(s):  
P. W. N. Keeling ◽  
W. Ruse ◽  
J. Bull ◽  
B. Hannigan ◽  
R. P. H. Thompson
Keyword(s):  
Chronic Hepatitis ◽  
Statistical Significance ◽  
Venous Blood ◽  
Zinc Content ◽  
Atomic Absorption Spectrophotometry ◽  
Zinc Extraction ◽  
Blood Samples ◽  
Peripheral Venous Blood ◽  
Absorption Spectrophotometry ◽  
Biopsy Specimens

1. 65Zn was injected intravenously during transjugular liver biopsy and, from simultaneous hepatic and peripheral venous blood samples, hepatointestinal 65Zn extraction was calculated. Hepatic zinc content was measured in biopsy specimens. 2. On the same occasion samples of liver tissue were taken and their zinc content was measured by atomic absorption spectrophotometry. 3. Seven patients with cirrhosis had significantly lower hepatic zinc content and hepatointestinal zinc extraction than six control patients with mild liver disease. Six patients with chronic hepatitis had a mean hepatointestinal zinc extraction higher than control patients, whereas their mean hepatic zinc content was lower, although the former difference did not achieve statistical significance. 4. These results demonstrate that hepatointestinal extraction of zinc is impaired in cirrhosis, but not in chronic hepatitis.

scholarly journals No association between the intake of marine n-3 PUFA during the second trimester of pregnancy and factors associated with cardiometabolic risk in the 20-year-old offspring

2013 ◽  
Vol 110 (11) ◽  
pp. 2037-2046 ◽  
Author(s):  
Dorte Rytter ◽  
Bodil H. Bech ◽  
Thorhallur Halldorsson ◽  
Jeppe H. Christensen ◽  
Erik B. Schmidt ◽  
...  
Keyword(s):  
Clinical Examination ◽  
Cardiometabolic Risk ◽  
Venous Blood ◽  
Second Trimester ◽  
Short Term ◽  
Pufa Intake ◽  
Factors Associated ◽  
Regression Modelling ◽  
Offspring Adiposity

The intake of marine n-3 PUFA has been shown to decrease the risk of CVD in a number of studies. Since the development of CVD is often a lifelong process, marine n-3 PUFA intake early in life may also affect the development of later CVD. The aim of the present study was to investigate the association between maternal intake of marine n-3 PUFA during the second trimester of pregnancy and factors associated with cardiometabolic risk in the 20-year-old offspring. The study was based on the follow-up of the offspring of a Danish pregnancy cohort who participated in a study conducted from 1988 to 1989. A total of 965 pregnant women were originally included in the cohort and detailed information about the intake of marine n-3 PUFA during the second trimester was collected. In 2008–9, the offspring were invited to participate in a clinical examination including anthropometric, blood pressure (BP) and short-term heart rate variability measurements. Also, a fasting venous blood sample was drawn from them. Multiple linear regression modelling, using the lowest quintile of marine n-3 PUFA intake as the reference, was used to estimate the association with all outcomes. A total of 443 offspring participated in the clinical examination. No association between the intake of marine n-3 PUFA during the second trimester of pregnancy and offspring adiposity, glucose metabolism, BP or lipid profile was found. In conclusion, no association between the intake of marine n-3 PUFA during the second trimester of pregnancy and the factors associated with cardiometabolic risk in the 20-year-old offspring could be detected.

Sign in / Sign up

Export Citation Format

Share Document